Cargando…
Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1
BACKGROUND: Colorectal cancer (CRC) is one of the most commonly diagnosed human malignancies. Ribosomal protein L31 (RPL31, aka eL31) is a component of the 60S large ribosomal subunit, and its expression pattern and functional role in CRC have not been reported. METHODS: Herein, we identified that e...
Autores principales: | Sharen, Gaowa, Li, Xiongfeng, Sun, Jiaxin, Zhang, Lei, Xi, Wen, Zhao, Xiaodong, Han, Fei, Jia, Longlong, A, Rong, Cheng, Haidong, Hou, Mingxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617412/ https://www.ncbi.nlm.nih.gov/pubmed/36309731 http://dx.doi.org/10.1186/s12967-022-03663-6 |
Ejemplares similares
-
Long-Term Outcomes Comparison of Endoscopic Resection With Gastrectomy for Treatment of Early Gastric Cancer: A Systematic Review and Meta-Analysis
por: An, Liangliang, et al.
Publicado: (2019) -
DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022) -
DEPDC1 as a crucial factor in the progression of human osteosarcoma
por: Shen, Lin, et al.
Publicado: (2022) -
DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma
por: Zhou, Chao, et al.
Publicado: (2019) -
Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
por: Xu, Lin, et al.
Publicado: (2021)